Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2019 | CAR-T data to watch out for at ASH 2019

David Maloney • 15 Jun 2019
EHA 2019
General

David Maloney, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, discusses the CAR T-cell therapy data he is expecting to be presented at ASH 2019 at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands. Prof. Maloney specifically mentions upcoming data on lisocabtagene maraleucel.

More from David Maloney

Expanding the CAR platform in NHL
David Maloney et al. • 17 Oct 2023
14:23
Highlights from Day 2: addressing challenges in CAR-T therapy for ALL, AML, CLL & more…
David Maloney et al. • 30 Apr 2022
10:21
Advances in CAR-T therapy for lymphoma
Caron Jacobson et al. • 1 May 2022
4:36
Highlights from the immunotherapy in CLL session
David Maloney • 20 Sep 2021

Related Videos

1:12
The contribution of viral infections, such as EBV, to post-transplant lymphoproliferative disease
Susan Prockop • 16 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
The content of VJHemOnc is intended for healthcare professionals